Agenus shared a post by OncoDaily on LinkedIn, adding:
“Congratulations to Steven O’Day, Chief Medical Officer at Agenus, on being named Chair of OncoDaily’s World Melanoma Day 2026 Global Symposium.
Dr. O’Day’s leadership reflects a career-long commitment to advancing immunotherapy and addressing the urgent needs of patients with melanoma, including those whose cancers remain resistant to current treatment approaches.
We are proud to support this global dialogue on the future of melanoma care.
Register.”
Quoting OncoDaily‘s post:
“OncoDaily is proud to announce Dr. Steven O’Day as the Chair of ‘World Melanoma Day 2026 Global Symposium’.
The Chief Medical Officer at Agenus and a pioneer in cancer immunotherapy. Since joining in 2020, he has led the company’s expansion in immuno-oncology. With over three decades of experience as a medical oncologist, he has played a key role in advancing cancer therapies, particularly in the development of CTLA-4–targeted treatments, and continues to drive innovation in the field.
May 11, 2026
Other Articles About Agenus On OncoDaily.